Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Chronic Azithromycin Use in Cystic Fibrosis and Concern for Treatment-Emergent Pathogens

Chronic Azithromycin Use in Cystic Fibrosis and Concern for Treatment-Emergent Pathogens

Resource Type

CF Research News

Authors

Cogen JD, Onchiri F, Emerson J, et al.

References

Ann Am Thorac Soc. 2018 Jun; 15(6): 702709 

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

macrolides [3]
Methicillin-resistant Staphylococcus aureus [4]
microbiology [5]

Date

Friday, June 15, 2018

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/chronic-azithromycin-use-cystic-fibrosis-and-concern-treatment

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/Cogen%202018_for%20CFRN.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/29474110 [3] https://www.ecfs.eu/research-article-keywords/macrolides [4] https://www.ecfs.eu/research-article-keywords/methicillin-resistant-staphylococcus-aureus [5] https://www.ecfs.eu/research-article-keywords/microbiology [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines